Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 5/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29517378 | 0.78 | ERN1 (0.35) | CYP2A6KDM4ETDP1ERN1TRIM24 | |
| SCHEMBL12419808 | 0.72 | ALDH1A1 (0.58) | KDM4EMEN1KMT2A | |
| SCHEMBL21580184 | 0.71 | — | — | |
| SCHEMBL1419542 | 0.70 | CYP2A6 (0.45) | CYP2A6TDP1MEN1LMNATHRB | |
| SCHEMBL225281 | 0.69 | — | — | |
| SCHEMBL2183638 | 0.69 | — | — | |
| SCHEMBL868397 | 0.69 | MAPT (0.35) | — | |
| SCHEMBL5435189 | 0.68 | CYP2A6 (0.36) | CYP2A6TDP1MEN1LMNATHRB | |
| SCHEMBL14942555 | 0.67 | — | — | |
| SCHEMBL134580 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118124-A | Nitrogen-rich DOPO-based flame retardant, synthesis and application thereof | 常州大学 | 2025-06-10 | — | — | CN | claimed |
| CN-113429381-B | Bithiophene rotor derivative 3 '-acetyl- [2,2' -bithiophene ] -3-formaldehyde and preparation method and application thereof | 山西大同大学 | 2023-03-21 | — | — | CN | claimed |
| CN-113429381-A | Bithiophene rotor derivative 3 '-acetyl- [2,2' -bithiophene ] -3-formaldehyde, preparation method and application | 山西大同大学 | 2021-09-24 | — | — | CN | claimed |
| US-8361484-B2 | Polymer systems for lung volume reduction therapy | AERIS THERAPEUTICS, INC. (US) | 2013-01-29 | — | — | US | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-20030119178-A1 | DNA chip and its preparation | SATO KOZO (JP) | 2003-06-26 | — | — | US | claimed |
| US-6448238-B1 | BORONIC ACIDS USED WITH BETA-LACTAM ANTIBIOTICS, SUCH AS AMOXICILLIN OR CEFTAZIDIME, TO TREAT BETA-LACTAM ANTIBIOTIC RESISTANT BACTERIAL INFECTIONS | NORTHWESTERN UNIVERSITY | 2002-09-10 | — | — | US | claimed |
| US-6417174-B1 | BACTERICIDES | NORTHWESTERN UNIVERSITY | 2002-07-09 | — | — | US | claimed |
| US-20010011129-A1 | DNA chip and its preparation | FUJI PHOTO FILM CO., LTD.; | 2001-08-02 | — | — | US | claimed |
| EP-1009415-A4 | INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR | UNIV NORTHWESTERN (US) | 2000-10-25 | — | — | EP | claimed |
| EP-1009415-A1 | INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR | NORTHWESTERN UNIVERSITY (US) | 2000-06-21 | — | — | EP | claimed |
| US-6075014-A | BACTERICIDES | NORTHWESTERN UNIVERSITY (US) | 2000-06-13 | — | — | US | claimed |
| WO-1998056392-A1 | INHIBITORS OF β-LACTAMASES AND USES THEREFOR | NORTHWESTERN UNIVERSITY (US) | 1998-12-17 | — | — | WO | claimed |
| EP-4667458-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING SOS1 INHIBITOR AND ANTICANCER DRUG | Kanaph Therapeutics Inc. (KR) | 2025-12-24 | — | — | EP | disclosed |
| CN-120118124-A | Nitrogen-rich DOPO-based flame retardant, synthesis and application thereof | 常州大学 | 2025-06-10 | — | — | CN | disclosed |
| WO-1999018099-A1 | ARYL THIOPHENE DERIVATIVES AS PDE IV INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 1999-04-15 | — | — | WO | disclosed |
| WO-1998056392-A1 | INHIBITORS OF β-LACTAMASES AND USES THEREFOR | NORTHWESTERN UNIVERSITY (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998016503-A2 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010011129-A1 | DNA chip and its preparation | STUB1, DNMT3A, PCNA | CYP2A6 2437/4885KDM4E 769/4885TDP1 117/4885 |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | CYP2A6 1752/4885KDM4E 1589/4885TDP1 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.